Abstract
Biologic response modifiers have revolutionized the treatment of a number of chronic inflammatory diseases, including rheumatoid arthritis, seronegative spondyloarthropathies, psoriasis, and inflammatory bowel disease. The tumor necrosis factor-alpha (TNF-alpha) inhibitors have a targeted strategy for the treatment of systemic inflammation and improve patient symptoms and function. However, TNF-alpha has demonstrated importance in the protection against several pathogens, leaving patients on this therapy more prone to infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Scott L. Etanercept: a review of its use in autoimmune inflammatory diseases. Drugs. 2014;74:1379–410.
Doss GP, Agoramoorthy G, Chakraborty C. TNF/TNFR: drug target for autoimmune and immune-mediated inflammatory diseases. Front Biosci (Landmark Ed). 2014;19:1028–40.
Koo S, Marty FM, Baden L. Infectious complications associated with immunomodulating biologic agents. Hematol Oncol Clin North Am. 2010;25(1):117–38.
Strangfeld A, Listing J. Infection and musculoskeletal conditions: bacterial and opportunistic infections during anti-TNF therapy. Best Pract Res Clin Rheumatol. 2006;20(6):118–95.
Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098.
Darabi K, Jaiswal R, Hostetler S, et al. Infectious complications in patients with psoriasis and rheumatoid arthritis treated with antitumor necrosis factor agents and methotrexate. J Drugs Dermatol. 2009;8(2):175–8.
Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systemic review and meta-analysis of rare harmful effects in randomized control trials. JAMA. 2006;295:2275–85.
Listing J, Strangfeld A, Kary S, et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum. 2005;52:3403.
Kroesen S, Widner AF, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology. 2003;42(5):617–21.
Dixon WG, Symmons DP, Lunt M, et al. Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. Arthritis Rheum. 2007;56:2896.
Fu B, Lunt M, Galloway J, et al. A threshold hazard model for estimating serious infection risk following anti-tumor necrosis factor therapy in rheumatoid arthritis patients. J Biopharm Stat. 2013;23:461–7.
Darley MD, Saad D, Haydoura S, et al. Spinal epidural abscess following minimally invasive dental examination in a rheumatoid arthritis patient receiving methotrexate, glucocorticoids, and anti-tumor necrosis factor therapy. J Clin Rheumatol. 2015;21(1):52–3.
Rose AM, Barnett J, Morris-Jones S, et al. Staphylococcus lugdunensis septic arthritis and epidural abscess in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor therapy. Rheumatology (Oxford). 2014;53(12):2231.
Vasoo S, Gurnanu P, Agustin T, et al. Chest pain as presenting symptom of Staphylococcus aureus epidural abscess associated with anti-tumor necrosis factor therapy. J Clin Rheumatol. 2009;15(8):39608.
Smith AP, Musacchio MJ, O’Toole JE, et al. Spinal epidural abscess associated with infliximab treatment for psoriatic arthritis. Case report. J Neurosurg Spine. 2008;9(3):261–4.
Hooten WM, Kinney MO, Huntoon MA, et al. Epidural abscess and meningitis after epidural corticosteroid injection. Mayo Clin Proc. 2004;79(5):682–6.
Diehn FE. Imaging of spine infection. Radiol Clin North Am. 2012;50(4):777–98.
Reihsaus E, Waldbaur H, Seeling W. Spinal epidural abscess: a meta-analysis of 915 patients. Neurosurg Rev. 2000;232:175–204.
Grewel S, Hocking G, Wildsmith JAW. Epidural abscesses. Br J Anaesth. 2006;96(3):292–302.
Tang HJ, Lin HJ, Liu YC, et al. Spinal epidural abscess—experience with 46 patients and evaluation of prognostic factors. J Infect. 2002;45:76–81.
Davis D, Salazar A, Chan T, et al. Prospective evaluation of a clinical decision guideline to diagnose spinal epidural abscess in patients who present to the emergency department with spine pain. J Neurosurg Spine. 2011;14(6):765.
Felton B, Dao T, Gerstner B, Letarte S. Diagnosis of spinal epidural abscess by abdominal-film radiography. West J Emerg Med. 2014;15(7):885–6.
Tompkins M, Panuncialman I, Lucas P, et al. Spinal epidural abscess. J Emerg Med 2010; 39(3): 384–90
Patel A, Alton T, Bransford R, et al. Spinal epidural abscesses: risk factors, medical vs. surgical management, a retrospective review of 128 cases. Spine J. 2014;14:326–30.
Wheeler D, Keiser P, Rigamonti D, Keay S. Medical management of spinal epidural abscesses: case report and review. Clin Infect Dis. 1992;15:22.
Siddiq F, Chowfin A, Tight R, et al. Medical vs. surgical management of spinal epidural abscess. Arch Intern Med. 2004;164:2409.
Curry WT Jr, Hoh BL, Amin-Hanjani S, Eskandar EN. Spinal epidural abscess: clinical presentation, management, and outcome. Surg Neurol. 2005;63:364.
Arko L IV, Quach E, Nguyen V, Chang D, Sukul V, Kim BS. Medical and surgical management of spinal epidural abscess: a systematic review. Neurosurg Focus. 2014;37(2):E4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Nagpal, G. (2018). Epidural Abscess After Epidural Steroid Injection in a Patient on TNF-Alpha Inhibitors. In: Anitescu, M., Benzon, H., Wallace, M. (eds) Challenging Cases and Complication Management in Pain Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-60072-7_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-60072-7_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60070-3
Online ISBN: 978-3-319-60072-7
eBook Packages: MedicineMedicine (R0)